MEDIFAST INC(MED)— Stock Profile, AI Score & Financials

Consumer Staples · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

MEDIFAST INC (MED) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores MED at 19.1/100 on a 32-signal composite quality model, placing it at rank #2,797 of 2,960 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (0.9) and institutional flow (5.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 40.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), MEDIFAST INC reports quarterly revenue of $76.4M, net income of $-3.1M, an operating margin of -5.7%. Top institutional holders of MED by reported 13-F value include RENAISSANCE TECHNOLOGIES, Steamboat Capital Partners, SUSQUEHANNA INTERNATIONAL GROUP, LLP, based on the most recent SEC filings. MED trades on the NYSE exchange and files with the SEC under CIK 910329. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MED daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MEDIFAST INC directly from SEC EDGAR.